Cargando…

Patients’ willingness to participate in clinical trials and their views on aspects of cancer research: results of a prospective patient survey

BACKGROUND: Recruitment to clinical trials can be challenging and slower than anticipated. This prospective patient survey aimed to investigate the proportion of patients approached about a trial who agree to participate, their motivations for trial participation and their views on aspects of cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moorcraft, Sing Yu, Marriott, Cheryl, Peckitt, Clare, Cunningham, David, Chau, Ian, Starling, Naureen, Watkins, David, Rao, Sheela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706669/ https://www.ncbi.nlm.nih.gov/pubmed/26745891 http://dx.doi.org/10.1186/s13063-015-1105-3

Ejemplares similares

Characterising timing and pattern of relapse following surgery for localised oesophagogastric adenocarcinoma: a retrospective study
por: Moorcraft, Sing Yu, et al.
Publicado: (2016)

Prognostic factors and treatment outcomes in patients with Small Bowel Adenocarcinoma (SBA): The Royal Marsden Hospital (RMH) experience
por: Khan, Khurum, et al.
Publicado: (2015)

Detecting and Tracking Circulating Tumour DNA Copy Number Profiles during First Line Chemotherapy in Oesophagogastric Adenocarcinoma
por: Davidson, Michael, et al.
Publicado: (2019)

miR-21 expression and clinical outcome in locally advanced pancreatic cancer: exploratory analysis of the pancreatic cancer Erbitux, radiotherapy and UFT (PERU) trial
por: Khan, Khurum, et al.
Publicado: (2016)

Does cancer research focus on areas of importance to patients?
por: Moorcraft, Sing Yu, et al.
Publicado: (2016)

Outcomes of Patients with Early Onset Colorectal Cancer Treated in a UK Specialist Cancer Center
por: Georgiou, Alexandros, et al.
Publicado: (2019)

Genomic loss of heterozygosity and survival in the REAL3 trial
por: Smyth, Elizabeth C., et al.
Publicado: (2018)

Mutational signatures impact the evolution of anti-EGFR antibody resistance in colorectal cancer
por: Woolston, Andrew, et al.
Publicado: (2021)

Molecular profiling of colorectal pulmonary metastases and primary tumours: implications for targeted treatment
por: Moorcraft, Sing Y., et al.
Publicado: (2017)

Effect of perioperative FLOT versus ECF/ECX on short-term outcomes after surgery for resectable oesophagogastric adenocarcinoma: propensity score-matched study
por: Moussa, Osama, et al.
Publicado: (2022)

Targeting Vascular Endothelial Growth Factor in Oesophagogastric Cancer: A Review of Progress to Date and Immunotherapy Combination Strategies
por: Butters, Oliver, et al.
Publicado: (2019)

ctDNA guided adjuvant chemotherapy versus standard of care adjuvant chemotherapy after curative surgery in patients with high risk stage II or stage III colorectal cancer: a multi-centre, prospective, randomised control trial (TRACC Part C)
por: Slater, Susanna, et al.
Publicado: (2023)

Impact of pharmacogenomic DPYD variant guided dosing on toxicity in patients receiving fluoropyrimidines for gastrointestinal cancers in a high-volume tertiary centre
por: Lau, David K., et al.
Publicado: (2023)

Comparison of a coaxial versus non-coaxial liver biopsy technique in an oncological setting: diagnostic yield, complications and seeding risk
por: Fotiadis, Nicos, et al.
Publicado: (2020)

Contemporary Views of Research Participant Willingness to Participate and Share Digital Data in Biomedical Research
por: Pratap, Abhishek, et al.
Publicado: (2019)

Impact of tumour histological subtype on chemotherapy outcome in advanced oesophageal cancer
por: Davidson, Michael, et al.
Publicado: (2017)

Role of erlotinib in the management of pancreatic cancer
por: Starling, Naureen, et al.
Publicado: (2006)

Rapid access clinic for unexplained lymphadenopathy and suspected malignancy: prospective analysis of 1000 patients
por: Kühnl, Andrea, et al.
Publicado: (2018)

Ibrutinib in c-MYC and HER2 Amplified Oesophagogastric Carcinoma: Results of the Proof-of-Concept iMYC Study
por: Turkes, Fiona, et al.
Publicado: (2022)

Diagnostic Accuracy and Safety of Coaxial System in Oncology Patients Treated in a Specialist Cancer Center With Prospective Validation Within Clinical Trial Data
por: Khan, Khurum, et al.
Publicado: (2020)

Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment
por: Newey, Alice, et al.
Publicado: (2019)

The FOCCUS study: a prospective evaluation of the frequency, severity and treatable causes of gastrointestinal symptoms during and after chemotherapy
por: Andreyev, H. Jervoise N., et al.
Publicado: (2020)

EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancers
por: Smyth, Elizabeth C, et al.
Publicado: (2021)

The evolving immunotherapeutic landscape in advanced oesophagogastric cancer
por: Flynn, Michael, et al.
Publicado: (2018)

Contemporary Tailored Oncology Treatment of Biliary Tract Cancers
por: Turkes, Fiona, et al.
Publicado: (2019)

The Mutational Concordance of Fixed Formalin Paraffin Embedded and Fresh Frozen Gastro-Oesophageal Tumours Using Whole Exome Sequencing
por: Chong, Irene Y., et al.
Publicado: (2021)

SARS-CoV-2 Vaccine Immunogenicity in Patients with Gastrointestinal Cancer Receiving Systemic Anti-Cancer Therapy
por: Lau, David K, et al.
Publicado: (2022)

Immunotherapy and pancreatic cancer: unique challenges and potential opportunities
por: Young, Kate, et al.
Publicado: (2018)

Willingness and Motivation of Saudi Patients with Keratoconus to Participate in Clinical Trials
por: Al Mahfud, Shahd A, et al.
Publicado: (2021)

CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids
por: Gonzalez-Exposito, Reyes, et al.
Publicado: (2019)

Up-to-Date Tailored Systemic Treatment in Pancreatic Ductal Adenocarcinoma
por: Fong, Caroline Y. K., et al.
Publicado: (2019)

Willingness to participate in geolocation-based research
por: Ochoa Gómez, Carlos
Publicado: (2022)

Factors influencing patient willingness to participate in genetic research after a myocardial infarction
por: Lanfear, David E, et al.
Publicado: (2011)

Willingness of patients with sarcoma to participate in cancer surveillance research: a cross-sectional patient survey
por: Schneider, Patricia, et al.
Publicado: (2021)

Case Report: Response to ipilimumab and nivolumab in a patient with adrenocortical carcinoma
por: Charles, Rebecca, et al.
Publicado: (2023)

Trastuzumab in the management of gastroesophageal cancer: patient selection and perspectives
por: Davidson, Michael, et al.
Publicado: (2016)

Sociodemographic and psychological characteristics influencing patients’ willingness to participate in clinical trials
por: Gouveia, Rita, et al.
Publicado: (2022)

Pathological regression of primary tumour and metastatic lymph nodes following chemotherapy in resectable OG cancer: pooled analysis of two trials
por: Athauda, Avani, et al.
Publicado: (2023)

Willingness to participate in prevention programs for cardiometabolic diseases
por: Petter, Jessica, et al.
Publicado: (2015)

Willingness to participate in health research: Tunisian survey
por: Bouida, Wahid, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_oh7daulb8canai1b567h7d0nun